|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.82 USD | -1.16% |
|
-7.07% | -24.79% |
| 05-15 | Collegium Pharmaceutical, Inc. Announces Appointment of Michael Donovan as Director | CI |
| 05-12 | Collegium completes acquisition of Azstarys® from Corium Therapeutics | RE |
| Market Cap | 1.13B 991M 917M 844M 1.6B 108B 1.63B 10.93B 4.29B 53.08B 4.24B 4.15B 183B | P/E 2026 * |
13.1x | P/E 2027 * | 9.34x |
|---|---|---|---|---|---|
| Enterprise Value | 1.88B 1.65B 1.53B 1.41B 2.66B 180B 2.71B 18.2B 7.14B 88.37B 7.06B 6.91B 305B | EV / Sales 2026 * |
2.15x | EV / Sales 2027 * | 1.64x |
| Free-Float |
77.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Collegium Pharmaceutical, Inc.
| 1 day | -1.16% | ||
| 1 week | -7.07% | ||
| Current month | -3.81% | ||
| 1 month | +0.52% | ||
| 3 months | -2.25% | ||
| 6 months | -26.35% | ||
| Current year | -24.79% |
| 1 week | 34.57 |  | 36.73 |
| 1 month | 31.69 | | 38.5 |
| Current year | 30.13 | | 49.31 |
| 1 year | 29.19 | | 50.79 |
| 3 years | 20.95 | | 50.79 |
| 5 years | 14.04 | | 50.79 |
| 10 years | 7.37 | | 50.79 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikram Karnani
CEO | Chief Executive Officer | 51 | 12/11/2024 |
Colleen Tupper
DFI | Director of Finance/CFO | 50 | 24/05/2021 |
Thomas Smith
CTO | Chief Tech/Sci/R&D Officer | 65 | 23/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gino Santini
CHM | Chairman | 69 | 15/05/2025 |
John Freund
BRD | Director/Board Member | 72 | 01/02/2014 |
Garen Bohlin
BRD | Director/Board Member | 78 | 01/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-08 | Fiscal year | Chairman | 17,400 | 0.0536% | ||
| 05-18 | Sell | Director | -20 | 0.0001% | ||
| 05-15 | Fiscal year | Director | 21,527 | 0.0664% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.16% | -7.07% | +7.07% | +64.01% | 1.14B | |
| -0.56% | -1.52% | +49.04% | +171.88% | 1,060B | |
| +0.31% | -0.60% | +64.29% | +62.31% | 619B | |
| -0.03% | -2.65% | +28.86% | +85.64% | 438B | |
| -1.75% | -0.33% | +28.78% | +23.58% | 333B | |
| +0.24% | -0.42% | +29.46% | +47.26% | 282B | |
| -1.75% | -10.57% | +20.67% | +22.07% | 267B | |
| +0.67% | +1.03% | -26.10% | -37.96% | 218B | |
| -0.81% | -1.63% | +22.07% | +58.33% | 196B | |
| +1.21% | +1.38% | +19.85% | +71.29% | 161B | |
| Average | -0.33% | -2.59% | +24.40% | +56.84% | 357.51B | |
| Weighted average by Cap. | -0.28% | -2.12% | +36.26% | +83.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 875M 767M 710M 654M 1.24B 83.71B 1.26B 8.47B 3.32B 41.11B 3.28B 3.21B 142B | 886M 777M 720M 662M 1.25B 84.79B 1.28B 8.58B 3.36B 41.64B 3.33B 3.25B 144B |
| Net income | 108M 94.92M 87.92M 80.89M 153M 10.36B 156M 1.05B 411M 5.09B 406M 398M 17.57B | 158M 139M 129M 118M 224M 15.15B 228M 1.53B 601M 7.44B 594M 581M 25.7B |
| Net Debt | 751M 659M 610M 561M 1.06B 71.87B 1.08B 7.27B 2.85B 35.29B 2.82B 2.76B 122B | 328M 287M 266M 245M 463M 31.36B 472M 3.17B 1.24B 15.4B 1.23B 1.2B 53.19B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/07/26 | $34.82 | -1.16% | 343,220 |
| 10/07/26 | $35.23 | -1.62% | 286,216 |
| 09/07/26 | $35.81 | -0.06% | 466,329 |
| 08/07/26 | $35.83 | -1.67% | 445,359 |
| 07/07/26 | $36.44 | -2.75% | 471,253 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COLL Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
